314930 — Biodyne Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual income statement for Biodyne Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,671	3,763	12,210	4,089	5,271
Cost of Revenue
Gross Profit	479	499	9,305	684	2,438
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Total Operating Expenses	5,497	6,106	5,527	6,139	7,001
Operating Profit	-1,826	-2,343	6,683	-2,051	-1,730
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-5,060	-11,138	7,366	-1,221	-141
Provision for Income Taxes
Net Income After Taxes	-4,454	-10,857	5,611	-992	10.8
Net Income Before Extraordinary Items
Net Income	-4,454	-10,857	5,611	-992	10.8
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-4,454	-10,857	5,611	-992	10.8
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-192	-367	182	-31	-0.626
Dividends per Share